ATE357933T1 - Formulierungen von quinapril und verwandte ace- hemmer - Google Patents
Formulierungen von quinapril und verwandte ace- hemmerInfo
- Publication number
- ATE357933T1 ATE357933T1 AT03729543T AT03729543T ATE357933T1 AT E357933 T1 ATE357933 T1 AT E357933T1 AT 03729543 T AT03729543 T AT 03729543T AT 03729543 T AT03729543 T AT 03729543T AT E357933 T1 ATE357933 T1 AT E357933T1
- Authority
- AT
- Austria
- Prior art keywords
- formulations
- quinapril
- earth metal
- ace inhibitors
- metal carbonate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000005541 ACE inhibitor Substances 0.000 title abstract 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 title abstract 2
- JSDRRTOADPPCHY-HSQYWUDLSA-N quinapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CC2=CC=CC=C2C1)C(O)=O)CC1=CC=CC=C1 JSDRRTOADPPCHY-HSQYWUDLSA-N 0.000 title abstract 2
- 229960001455 quinapril Drugs 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- -1 alkaline-earth metal carbonate Chemical class 0.000 abstract 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- 150000007514 bases Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000000890 drug combination Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS6233 | 2002-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE357933T1 true ATE357933T1 (de) | 2007-04-15 |
Family
ID=36701209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03729543T ATE357933T1 (de) | 2002-01-15 | 2003-01-14 | Formulierungen von quinapril und verwandte ace- hemmer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050118259A1 (de) |
| EP (1) | EP1513555B1 (de) |
| AT (1) | ATE357933T1 (de) |
| AU (1) | AU2003235579A1 (de) |
| DE (1) | DE60312857T2 (de) |
| EA (1) | EA007981B1 (de) |
| ES (1) | ES2283774T3 (de) |
| IS (1) | IS2440B (de) |
| UA (1) | UA78542C2 (de) |
| WO (1) | WO2003059388A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005027881A2 (en) * | 2003-09-23 | 2005-03-31 | Texcontor Etablissement | Stable quinapril compositions |
| US20080234353A1 (en) * | 2004-03-24 | 2008-09-25 | Reynir Eyjolfsson | Formulations of Ramipril |
| ES2603856T3 (es) | 2004-03-29 | 2017-03-01 | Les Laboratoires Servier | Procedimiento para preparar una composición farmacéutica sólida |
| SI21800A (sl) | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
| GB0518129D0 (en) * | 2005-09-06 | 2005-10-12 | Arrow Int Ltd | Ramipril formulation |
| GB2431579A (en) * | 2005-10-28 | 2007-05-02 | Arrow Int Ltd | Ramipril formulations |
| US20070098782A1 (en) * | 2005-10-28 | 2007-05-03 | Selamine Limited | Ramipril Formulation |
| CA2836545C (en) | 2006-06-16 | 2016-08-09 | Lek Pharmaceuticals D.D. | Pharmaceutical composition comprising telmisartan and hydrochlorothiazide |
| GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
| GB0624082D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril metal salts |
| GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
| GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
| WO2008132756A1 (en) * | 2007-05-01 | 2008-11-06 | Lupin Limited | Stable pharmaceutical compositions of ramipril |
| TR200906322A2 (tr) | 2009-08-17 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Çözünürlük ve stabilite özellikleri geliştirilmiş granüller. |
| PL227900B1 (pl) | 2012-11-15 | 2018-01-31 | Adamed Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| HU222489B1 (hu) * | 1990-07-25 | 2003-07-28 | Novartis Ag. | Stabilizált gyógyszerkészítmények és eljárás az előállításukra |
| US5292520A (en) * | 1990-09-13 | 1994-03-08 | Akzo N.V. | Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer |
| US5573780A (en) * | 1995-08-04 | 1996-11-12 | Apotex Usa Inc. | Stable solid formulation of enalapril salt and process for preparation thereof |
| HUP0102260A3 (en) * | 1998-06-05 | 2002-12-28 | Warner Lambert Co | Stabilization of compositions containing ace inhibitors using magnesium oxide |
| EP1126880A2 (de) * | 1998-11-06 | 2001-08-29 | G.D. SEARLE & CO. | Kombinationstherapie von angiotensin-konvertierendem enzym hemmer und aldosterone antagonist zur reduzierung des erkrankungs- und todesfallrisikos von kardiovaskuläre erkrankungen |
| RU2165251C1 (ru) * | 2000-09-06 | 2001-04-20 | Федеральное государственное унитарное предприятие Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко | Твердая лекарственная форма эналаприла и способ ее получения |
-
2003
- 2003-01-14 AU AU2003235579A patent/AU2003235579A1/en not_active Abandoned
- 2003-01-14 DE DE60312857T patent/DE60312857T2/de not_active Expired - Lifetime
- 2003-01-14 WO PCT/IS2003/000002 patent/WO2003059388A1/en active IP Right Grant
- 2003-01-14 US US10/501,454 patent/US20050118259A1/en not_active Abandoned
- 2003-01-14 EP EP03729543A patent/EP1513555B1/de not_active Expired - Lifetime
- 2003-01-14 EA EA200400942A patent/EA007981B1/ru not_active IP Right Cessation
- 2003-01-14 ES ES03729543T patent/ES2283774T3/es not_active Expired - Lifetime
- 2003-01-14 AT AT03729543T patent/ATE357933T1/de not_active IP Right Cessation
- 2003-01-14 UA UA20040806559A patent/UA78542C2/uk unknown
-
2004
- 2004-08-11 IS IS7394A patent/IS2440B/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20050118259A1 (en) | 2005-06-02 |
| WO2003059388A1 (en) | 2003-07-24 |
| DE60312857D1 (de) | 2007-05-10 |
| EP1513555A1 (de) | 2005-03-16 |
| UA78542C2 (en) | 2007-04-10 |
| IS2440B (is) | 2008-11-15 |
| ES2283774T3 (es) | 2007-11-01 |
| EP1513555B1 (de) | 2007-03-28 |
| AU2003235579A1 (en) | 2003-07-30 |
| EA200400942A1 (ru) | 2004-12-30 |
| IS7394A (is) | 2004-08-11 |
| EA007981B1 (ru) | 2007-02-27 |
| DE60312857T2 (de) | 2008-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE357933T1 (de) | Formulierungen von quinapril und verwandte ace- hemmer | |
| WO2001076574A3 (en) | Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists | |
| WO2006050236A3 (en) | Compounds and methods of use thereof | |
| TR200103186T2 (tr) | MEK enzimlerinin inhibitörleri olarak kinolin türevleri | |
| DE60022525T2 (de) | Ramipril zur vorbeugung von kardiovaskulären vorfällen | |
| TW200609005A (en) | Film-coated tablet with plural coating-layers | |
| DE60316552D1 (de) | Tablette mit hohem wirkstoffgehalt | |
| JP2004514737A5 (de) | ||
| WO2003080070A3 (en) | Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer | |
| DK1608346T3 (da) | Lægemiddeltilförselssammensætninger af alfa-hydroxysyreester og fremgangsmåder til anvendelse heraf | |
| CY1111698T1 (el) | Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης | |
| WO2006071844A8 (en) | Oxygen-impervious packaging and methods for storing thyroid hormone | |
| TR200401793T4 (tr) | Perindopril tuzu ve bunu içeren farmasötik bileşimler. | |
| EP1346732A3 (de) | Dosierungformen hygroskopisch aktiver Inhaltstoffe | |
| WO2006050053A3 (en) | Compounds and methods of use thereof | |
| CY1108231T1 (el) | Σταθερη στερεα δοσολογικη μορφη περιλαμβανουσα δεσμοπρεσσινη | |
| HK1086548A1 (en) | Deuterated catecholamine derivatives and medicaments comprising said compounds | |
| JO3106B1 (ar) | مستحضر صلب يشمل بيوجليتازون وجليمبيريد وإستر حمض دهني لعديد أوكسي إيثيلين سوربيتان | |
| ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
| TW200509919A (en) | Cathepsin S inhibitors | |
| WO2003093503A3 (en) | Method for bioequivalence determination using expression profiling | |
| ATE350064T1 (de) | Pharmazeutische zusammensetzungen von rapamycines | |
| CR8948A (es) | Composicion farmaceutica | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| CR8973A (es) | Composicion farmaceutica en forma de una forma de dosificacion solida soluble en agua |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |